Bereich
Rechtsmedizin
IRM · Dept. IV
Pulmonary capillaritis as a cause of lethal diffuse alveolar hemorrhage.
Süss C, Schwartz M, Hausmann R. Pulmonary capillaritis as a cause of lethal diffuse alveolar hemorrhage. Int J Legal Med 2023
04.07.2023Pulmonary capillaritis as a cause of lethal diffuse alveolar hemorrhage.
04.07.2023Int J Legal Med 2023
Süss Christine Elisabeth, Schwartz Melanie, Hausmann Roland
Novel Receptor-Binding-Based Assay for the Detection of Opioids in Human Urine Samples.
Bergerhoff M, Moosmann B. Novel Receptor-Binding-Based Assay for the Detection of Opioids in Human Urine Samples. Anal Chem 2023
27.01.2023Novel Receptor-Binding-Based Assay for the Detection of Opioids in Human Urine Samples.
27.01.2023Anal Chem 2023
Bergerhoff Maja, Moosmann Björn
Recommendations for the successful identification of altered human remains using standard and emerging technologies: Results of a systematic approach
Senst A, Cossu C. Recommendations for the successful identification of altered human remains using standard and emerging technologies: Results of a systematic approach . Forensic Science International: Genetics 2022
17.10.2022Recommendations for the successful identification of altered human remains using standard and emerging technologies: Results of a systematic approach
17.10.2022Forensic Science International: Genetics 2022
Senst Alina, Cossu Christian
Recommendations for the successful identification of altered human remains using standard and emerging technologies: Results of a systematic approach.
Senst A, Caliebe A, Drum M, Cossu C, Zieger M, Scheurer E, Schulz I. Recommendations for the successful identification of altered human remains using standard and emerging technologies: Results of a systematic approach. Forensic Sci Int Genet 2022; 62:102790.
17.10.2022Recommendations for the successful identification of altered human remains using standard and emerging technologies: Results of a systematic approach.
17.10.2022Forensic Sci Int Genet 2022; 62:102790
Senst Alina, Caliebe Amke, Drum Matthias, Cossu Christian, Zieger Martin, Scheurer Eva, Schulz Iris
Development of a non-radioactive mass spectrometry-based binding assay at the μ-opioid receptor and its application for the determination of the binding affinities of 17 opiates/opioids as well as of the designer opioid isotonitazene and five further 2-benzylbenzimidazoles
Volz M, Moosmann B. Development of a non-radioactive mass spectrometry-based binding assay at the μ-opioid receptor and its application for the determination of the binding affinities of 17 opiates/opioids as well as of the designer opioid isotonitazene and five further 2-benzylbenzimidazoles. Anal Chim Acta 2022; 1219:339978.
23.05.2022Development of a non-radioactive mass spectrometry-based binding assay at the μ-opioid receptor and its application for the determination of the binding affinities of 17 opiates/opioids as well as of the designer opioid isotonitazene and five further 2-benzylbenzimidazoles
23.05.2022Anal Chim Acta 2022; 1219:339978
Volz Madeleine Ramona, Moosmann Björn
Swiss collaborative exercise for Disaster Victim Identification (DVI): Covering situations with different levels of complexity
Cossu C. Swiss collaborative exercise for Disaster Victim Identification (DVI): Covering situations with different levels of complexity. 2021
23.09.2021Swiss collaborative exercise for Disaster Victim Identification (DVI): Covering situations with different levels of complexity
23.09.20212021
Cossu Christian
Cross reactivity of the CEDIA and HEIA benzodiazepine kits for 29 designer benzodiazepines and tofisopam
Erdmann J, Moosmann B. Cross reactivity of the CEDIA and HEIA benzodiazepine kits for 29 designer benzodiazepines and tofisopam. Drug Test Anal 2021; 13:1686-1688.
24.06.2021Cross reactivity of the CEDIA and HEIA benzodiazepine kits for 29 designer benzodiazepines and tofisopam
24.06.2021Drug Test Anal 2021; 13:1686-1688
Erdmann Joana, Moosmann Björn
New psychoactive substances—Designer benzodiazepines
Moosmann B. New psychoactive substances—Designer benzodiazepines. WIREs Forensic Science 2021; 3:1416-1439.
28.03.2021New psychoactive substances—Designer benzodiazepines
28.03.2021WIREs Forensic Science 2021; 3:1416-1439
Moosmann Björn
Fahreignungs-Gutachten bei komplexen medizinischen Sachverhalten
Liniger B. Fahreignungs-Gutachten bei komplexen medizinischen Sachverhalten. In: Jahrbuch zum Strassenverkehrsrecht. Zürich / St. Gallen: Dike, 2020. ISBN 978-3-03891-339-9. S. 263-280.
01.01.2021Fahreignungs-Gutachten bei komplexen medizinischen Sachverhalten
01.01.2021Dike, ISBN 978-3-03891-339-9
Liniger Bruno
Problematik der Sedativa und Hypnotika, mit Fokus auf Benzodiazepine und Z-Hypnotika, aus verkehrsmedizinischer Sicht
Steindl G. Problematik der Sedativa und Hypnotika, mit Fokus auf Benzodiazepine und Z-Hypnotika, aus verkehrsmedizinischer Sicht. In: Jahrbuch zum Strassenverkehrsrecht 2021. Zürich / St. Gallen: Dike, 2020. ISBN 978-3-03891-339-9. S. 247-261.
01.01.2021Problematik der Sedativa und Hypnotika, mit Fokus auf Benzodiazepine und Z-Hypnotika, aus verkehrsmedizinischer Sicht
01.01.2021Dike, ISBN 978-3-03891-339-9
Steindl Gerda
Plötzlicher Tod nach bronchoskopischer Dampfablationstherapie
Birchler A, Hausmann R. Plötzlicher Tod nach bronchoskopischer Dampfablationstherapie. Rechtsmedizin 2020
09.12.2020Plötzlicher Tod nach bronchoskopischer Dampfablationstherapie
09.12.2020Rechtsmedizin 2020
Birchler Andrea, Hausmann Roland
Morphology of direct and indirect rib fractures
Kissling S, Hausmann R. Morphology of direct and indirect rib fractures. International Journal of Legal Medicine 2020
14.09.2020Morphology of direct and indirect rib fractures
14.09.2020International Journal of Legal Medicine 2020
Kissling Steffen, Hausmann Roland
Verzögerter Todeseintritt nach Einnahme von Natrium-Pentobarbital
Kissling S, Blum S, Beyer J, Moosmann B, Hausmann R (2020). Verzögerter Todeseintritt nach Einnahme von Natrium-Pentobarbital. Präsentiert bei: DGRM Jahrestagung, Luzern
05.09.2020Verzögerter Todeseintritt nach Einnahme von Natrium-Pentobarbital
05.09.2020DGRM Jahrestagung
Kissling Steffen, Blum Simon, Beyer Jochen, Moosmann Björn, Hausmann Roland
Compound elevated fracture - reconstruction of an unusual skull injury
Kessler A, Hausmann R. Compound elevated fracture - reconstruction of an unusual skull injury. Int J Legal Med 2020
23.07.2020Compound elevated fracture - reconstruction of an unusual skull injury
23.07.2020Int J Legal Med 2020
Kessler Anne-Catherine, Hausmann Roland
Plötzlicher und unerwarteter Tod infolge einer akuten oberen gastrointestinalen Blutung bei ösophagelaer Dieulafoy-Läsion
Süss C, Hausmann R. Plötzlicher und unerwarteter Tod infolge einer akuten oberen gastrointestinalen Blutung bei ösophagelaer Dieulafoy-Läsion. Rechtsmedizin 2020
02.07.2020Plötzlicher und unerwarteter Tod infolge einer akuten oberen gastrointestinalen Blutung bei ösophagelaer Dieulafoy-Läsion
02.07.2020Rechtsmedizin 2020
Süss Christine, Hausmann Roland
Gross and histopathological pulmonary findings in a COVID-19 associated death during self-isolation
Suess C, Hausmann R. Gross and histopathological pulmonary findings in a COVID-19 associated death during self-isolation. Int J Legal Med 2020; 134:1285-1290.
05.06.2020Gross and histopathological pulmonary findings in a COVID-19 associated death during self-isolation
05.06.2020Int J Legal Med 2020; 134:1285-1290
Suess Christine, Hausmann Roland
Alkohol-, Drogen- und Medikamenten-Problematik
Liniger B. Alkohol-, Drogen- und Medikamenten-Problematik - Verkehrsmedizinische Auflagen im Wandel. In: Jahrbuch Strassenverkehrsrecht 2020. Zürich / St. Gallen: Dike, 2020. ISBN 978-3-03891-179-1. S. 195-207.
01.01.2020Alkohol-, Drogen- und Medikamenten-Problematik
01.01.2020Dike, ISBN 978-3-03891-179-1
Liniger Bruno
Morphologische Unterscheidungskriterien direkter und indirekter Rippenbrüche
Kissling S, Hausmann R (2019). Morphologische Unterscheidungskriterien direkter und indirekter Rippenbrüche. Präsentiert bei: DGRM Jahrestagung, Hamburg
15.09.2019Morphologische Unterscheidungskriterien direkter und indirekter Rippenbrüche
15.09.2019DGRM Jahrestagung
Kissling Steffen, Hausmann Roland
Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3‐fluorophenmetrazine (3‐FPM)
Grumann C, Huppertz L, Bisel P, Angerer V, Auwärter V. Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3‐fluorophenmetrazine (3‐FPM). Drug Testing and Analysis 2019; Epub ahead of print
19.02.2019Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3‐fluorophenmetrazine (3‐FPM)
19.02.2019Drug Testing and Analysis 2019; Epub ahead of print
Grumann Christina, Huppertz Laura M., Bisel Philippe, Angerer Verena, Auwärter Volker
Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864)
Moosmann B, Bisel P, Westphal F, Wilde M, Kempf J, Angerer V, Auwärter V. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864). Drug Test Anal 2019; 11:541-549.
05.02.2019Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864)
05.02.2019Drug Test Anal 2019; 11:541-549
Moosmann Björn, Bisel Philippe, Westphal Folker, Wilde Maurice, Kempf Jürgen, Angerer Verena, Auwärter Volker